Svas Biosana S p A : The Board of Directors of SVAS Biosana approves the short-form consolidated half-yearly financial statements as at 30 june 2023 -September 27, 2023 at 05:38 am EDT
EBITDA Margin 12.6% Consolidated EBIT: €4.2 million - EBIT Margin 7.7% Consolidated Net Profit: €2.3 million ...
Source: marketscreener.com